Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free USAC Stock Alerts

USA Compression Partners (USAC) Financials

USA Compression Partners logo
$29.54 +0.04 (+0.12%)
As of 11:02 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for USA Compression Partners

Annual Income Statements for USA Compression Partners

This table shows USA Compression Partners' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -154 -27 -265 -47 32 -643 -38 -18 20 82 103
Consolidated Net Income / (Loss)		 -154 -27 -265 -11 39 -595 10 30 68 100 111
Net Income / (Loss) Continuing Operations		 -154 -27 -265 -11 80 -595 10 30 68 100 111
Total Pre-Tax Income 		-153 -27 -263 -13 41 -593 11 31 70 102 116
Total Operating Income		 -136 -27 -263 65 168 -465 141 169 232 294 307
Total Gross Profit		 271 264 151 -177 1,169 462 438 470 561 638 669
Total Revenue		 271 264 277 37 1,397 668 633 705 846 950 998
Operating Revenue		 271 264 277 37 1,397 668 633 705 846 950 998
Total Cost of Revenue		 0.00 0.00 125 215 227 206 194 234 285 313 329
Operating Cost of Revenue		 - - 125 215 227 206 194 234 285 313 329
Total Operating Expenses		 406 291 414 -243 833 927 297 301 329 343 363
Selling, General & Admin Expense		 41 23 25 69 64 60 56 61 73 73 66
Depreciation Expense		 85 155 167 214 231 239 239 237 246 265 285
Impairment Charge		 199 - 223 8.67 5.89 628 5.12 1.49 12 0.91 7.81
Other Special Charges / (Income)		 -1.04 0.12 -0.37 13 0.94 0.15 -2.59 1.53 -1.67 4.94 3.82
Total Other Income / (Expense), net		 -18 -0.15 -0.22 -78 -254 -129 -130 -138 -162 -193 -190
Interest Expense		 18 - 0.00 78 127 129 130 138 170 198 190
Interest & Investment Income		 - - - - - - 0.00 0.00 7.45 5.68 0.00
Other Income / (Expense), net		 0.02 -0.15 -0.22 0.04 -127 0.09 0.11 0.09 0.13 0.11 0.10
Income Tax Expense		 1.09 -0.16 1.84 -2.47 2.19 1.33 0.87 1.02 1.37 2.23 4.87
Preferred Stock Dividends Declared		 - - 0.00 36 49 49 49 49 48 18 8.29
Basic Earnings per Share		 - - - ($2.76) - ($6.65) ($0.40) ($0.19) $0.21 $0.72 $0.85
Weighted Average Basic Shares Outstanding		 34.11M -8.40M 62.19M 0.00 0.00 96.82M 97.07M 97.78M 98.63M 113.39M 120.76M
Diluted Earnings per Share		 - - - ($2.76) - ($6.65) ($0.40) ($0.19) $0.20 $0.72 $0.85
Weighted Average Diluted Shares Outstanding		 34.11M -8.40M 62.19M 0.00 0.00 96.82M 97.07M 97.78M 100.68M 114.50M 121.27M
Weighted Average Basic & Diluted Shares Outstanding		 47.90M -8.40M 62.19M 80.88M 0.00 96.82M 97.07M 97.78M 98.63M 113.39M 120.76M
Cash Dividends to Common per Share		 $2.09 $2.10 $2.10 $1.58 $2.10 $2.10 $2.10 $2.10 $2.10 $2.10 $2.10

Quarterly Income Statements for USA Compression Partners

This table shows USA Compression Partners' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 8.71 1.63 19 27 15 21 16 27 33 28 38
Consolidated Net Income / (Loss)		 21 13 24 31 19 25 21 29 34 28 38
Net Income / (Loss) Continuing Operations		 21 13 24 31 19 25 21 29 34 28 38
Total Pre-Tax Income 		21 13 24 32 20 26 22 29 37 28 42
Total Operating Income		 61 69 67 77 76 75 69 77 84 77 91
Total Gross Profit		 142 152 154 157 158 481 164 164 173 169 213
Total Revenue		 217 225 229 235 240 246 245 250 250 252 331
Operating Revenue		 217 225 229 235 240 246 245 250 250 252 331
Total Cost of Revenue		 75 73 75 78 82 -235 82 86 77 84 118
Operating Cost of Revenue		 75 73 75 78 82 - 82 86 77 84 118
Total Operating Expenses		 81 83 87 80 82 406 94 87 89 92 122
Selling, General & Admin Expense		 20 19 23 14 15 20 19 13 17 18 35
Depreciation Expense		 64 62 63 65 67 69 70 71 71 72 87
Impairment Charge		 0.88 - 0.00 0.31 0.00 0.60 3.65 3.24 0.62 0.30 0.00
Other Special Charges / (Income)		 -3.87 2.27 1.25 -0.02 -0.12 3.83 1.33 0.04 0.83 1.63 -0.55
Total Other Income / (Expense), net		 -40 -55 -43 -46 -56 -49 -47 -48 -47 -48 -49
Interest Expense		 43 45 52 49 49 49 47 48 47 48 49
Other Income / (Expense), net		 3.46 -3.41 8.81 3.16 -6.20 6.25 0.03 0.02 0.02 0.03 0.02
Income Tax Expense		 0.26 0.36 0.47 0.46 0.79 0.50 1.54 0.39 2.41 0.54 4.12
Preferred Stock Dividends Declared		 12 11 4.39 4.39 4.39 4.39 4.39 1.95 1.95 - 0.00
Basic Earnings per Share		 $0.09 $0.01 $0.19 $0.23 $0.13 $0.17 $0.14 $0.22 $0.27 $0.22 $0.27
Weighted Average Basic Shares Outstanding		 98.29M 98.63M 102.54M 116.85M 117.02M 113.39M 117.51M 119.00M 122.68M 120.76M 142.75M
Diluted Earnings per Share		 $0.09 $0.01 $0.19 $0.23 $0.13 $0.17 $0.14 $0.22 $0.26 $0.23 $0.00
Weighted Average Diluted Shares Outstanding		 100.26M 100.68M 103.61M 117.97M 118.26M 114.50M 118.25M 119.50M 123.09M 121.27M 143.13M
Weighted Average Basic & Diluted Shares Outstanding		 98.29M 98.63M 102.54M 116.85M 117.02M 113.39M 117.51M 119.00M 122.68M 120.76M 142.75M
Cash Dividends to Common per Share		 $0.53 $0.53 $0.53 $0.53 $0.53 $0.53 $0.53 $0.53 $0.53 $0.53 $0.53

Annual Cash Flow Statements for USA Compression Partners

This table details how cash moves in and out of USA Compression Partners' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.00 2.93 -10 -3.91 -0.09 -0.01 -0.00 0.04 -0.02 0.00 8.55
Net Cash From Operating Activities		 117 130 136 226 301 293 265 261 272 341 394
Net Cash From Continuing Operating Activities		 117 130 136 226 301 293 265 259 272 340 394
Net Income / (Loss) Continuing Operations		 -154 -27 -265 -11 39 -595 10 30 68 100 111
Consolidated Net Income / (Loss)		 -154 -27 -265 -11 39 -595 10 30 68 100 111
Depreciation Expense		 85 155 167 214 231 239 239 237 246 265 285
Amortization Expense		 1.70 - 0.00 5.08 7.61 8.40 9.77 7.27 7.28 8.75 8.55
Non-Cash Adjustments To Reconcile Net Income		 202 3.07 225 34 19 640 15 17 34 27 19
Changes in Operating Assets and Liabilities, net		 -18 -1.19 9.23 -16 3.70 0.81 -8.74 -32 -84 -60 -29
Net Cash From Investing Activities		 -278 -37 -142 -780 -144 -105 -39 -130 -233 -202 -115
Net Cash From Continuing Investing Activities		 -278 -37 -142 -780 -144 -105 -39 -130 -233 -202 -115
Purchase of Property, Plant & Equipment		 -281 -62 -157 -267 -171 -109 -45 -134 -239 -205 -117
Sale of Property, Plant & Equipment		 1.74 25 15 7.47 22 2.65 4.47 3.68 5.33 1.34 2.25
Other Investing Activities, net		 1.16 - 0.00 0.41 4.18 1.32 1.56 0.60 0.54 1.50 0.07
Net Cash From Financing Activities		 161 -90 -3.67 549 -156 -188 -226 -131 -39 -139 -271
Net Cash From Continuing Financing Activities		 161 -90 0.00 549 -156 -188 -226 -131 -39 -139 -271
Repayment of Debt		 -349 - 0.00 -485 -1,499 -711 -666 -715 -864 -1,218 -2,541
Repurchase of Preferred Equity		 - - 0.00 - -244 -253 -255 -257 - -267 -267
Issuance of Debt		 480 - 0.00 698 750 777 698 0.00 1,089 1,000 2,545
Other Financing Activities, net		 -0.21 - 0.00 24 -15 -1.13 -3.17 -3.51 -6.45 -773 -8.51
Cash Interest Paid		 17 - 0.00 61 105 121 121 129 164 154 181
Cash Income Taxes Paid		 0.28 - 0.00 0.18 0.49 0.63 0.82 0.89 1.15 1.46 1.70

Quarterly Cash Flow Statements for USA Compression Partners

This table details how cash moves in and out of USA Compression Partners' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -0.03 0.01 -0.00 0.00 0.07 -0.07 -0.01 - -0.00 8.56 5.96
Net Cash From Operating Activities		 50 92 66 97 48 130 55 124 76 139 86
Net Cash From Continuing Operating Activities		 50 92 66 97 48 129 55 124 76 140 86
Net Income / (Loss) Continuing Operations		 21 13 24 31 19 25 21 29 34 28 38
Consolidated Net Income / (Loss)		 21 13 24 31 19 25 21 29 34 28 38
Depreciation Expense		 64 62 63 65 67 69 70 71 71 72 87
Amortization Expense		 1.82 1.82 2.00 2.26 2.25 2.25 2.24 2.23 2.13 1.95 1.83
Non-Cash Adjustments To Reconcile Net Income		 5.04 8.28 14 0.86 2.55 9.70 8.35 1.55 2.62 6.46 2.26
Changes in Operating Assets and Liabilities, net		 -42 6.19 -37 -2.92 -43 23 -47 21 -35 31 -44
Net Cash From Investing Activities		 -48 -79 -99 -48 -28 -27 -18 -22 -23 -51 -468
Net Cash From Continuing Investing Activities		 -48 -79 -99 -48 -28 -27 -18 -22 -23 -51 -468
Purchase of Property, Plant & Equipment		 -53 -79 -99 -49 -29 -29 -18 -23 -24 -52 -24
Acquisitions		 - - - - - - 0.00 - - - -444
Sale of Property, Plant & Equipment		 4.03 0.21 0.04 0.40 0.31 0.60 0.26 0.82 0.61 0.57 0.61
Other Investing Activities, net		 - - 0.00 - - 1.50 0.07 - - - 0.12
Net Cash From Financing Activities		 -2.02 -12 33 -49 -20 -103 -37 -102 -53 -80 388
Net Cash From Continuing Financing Activities		 -2.02 -12 33 -49 -20 -103 -37 -102 -53 -80 388
Repayment of Debt		 -224 -232 -478 -240 -251 -250 -242 -254 -1,016 -1,029 -145
Repurchase of Preferred Equity		 - -64 - - - -68 -67 - -67 -67 -67
Issuance of Debt		 287 291 1,325 257 297 -880 274 220 1,033 1,018 599
Other Financing Activities, net		 - -6.45 -749 - - -24 -2.23 -0.99 -2.64 -2.66 0.00
Cash Interest Paid		 68 18 45 16 77 16 75 15 72 19 52
Cash Income Taxes Paid		 0.26 - - - 0.31 - 0.00 - 0.20 - 4.09

Annual Balance Sheets for USA Compression Partners

This table presents USA Compression Partners' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1,510 1,472 1,719 3,775 3,730 2,949 2,768 2,666 2,737 2,746 2,620
Total Current Assets		 53 73 74 218 231 200 205 186 226 235 237
Cash & Equivalents		 0.01 0.07 4.01 0.10 0.01 0.00 0.00 0.04 0.01 0.01 8.56
Accounts Receivable		 31 41 33 127 137 112 113 84 95 89 82
Inventories, net		 19 30 33 89 92 85 86 94 115 134 134
Prepaid Expenses		 2.60 2.08 4.21 1.59 2.20 2.44 6.02 8.78 11 12 11
Plant, Property, & Equipment, net		 1,318 1,268 1,193 2,521 0.00 0.00 0.00 0.00 0.00 0.00 2,163
Total Noncurrent Assets		 139 132 452 1,035 3,499 2,749 2,563 2,479 2,510 2,511 221
Goodwill		 36 36 253 619 619 - - - - - 0.00
Intangible Assets		 79 75 198 393 363 334 304 275 246 216 187
Other Noncurrent Operating Assets		 6.85 6.74 0.21 23 2,517 2,415 2,259 2,204 2,265 2,294 34
Total Liabilities & Shareholders' Equity		 1,510 1,472 1,719 4,676 3,730 2,949 2,869 2,666 2,737 2,746 2,620
Total Liabilities		 1,510 1,472 54 1,918 2,073 2,134 2,190 2,305 2,554 2,718 2,732
Total Current Liabilities		 61 56 47 150 189 170 188 174 188 191 187
Accounts Payable		 24 13 3.36 24 22 14 23 35 40 27 28
Accrued Expenses		 21 27 42 94 119 110 114 76 85 99 94
Current Deferred Revenue		 17 17 2.22 31 48 47 51 62 63 64 65
Total Noncurrent Liabilities		 1,448 1,416 6.99 1,769 1,883 1,963 2,002 2,131 2,366 2,527 2,546
Long-Term Debt		 729 685 - 1,759 1,852 1,927 1,973 2,107 2,336 2,503 2,524
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - - - - 5.24
Other Noncurrent Operating Liabilities		 719 731 6.99 9.83 31 36 29 24 30 25 16
Commitments & Contingencies		 - - - - 0.00 0.00 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.00 0.00 0.00 0.00 1,181 338 101 -116 -293 -141 -113
Total Preferred & Common Equity		 0.00 0.00 0.00 0.00 1,181 338 101 -116 -293 -141 -113
Total Common Equity		 0.00 0.00 0.00 0.00 1,181 338 101 -116 -293 -141 -113
Common Stock		 - - - - 1,167 324 - -125 -293 -141 -113

Quarterly Balance Sheets for USA Compression Partners

This table presents USA Compression Partners' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 2,673 2,658 2,691 2,706 2,804 2,822 2,804 2,713 2,671 2,659 3,734
Total Current Assets		 180 186 212 224 249 256 262 243 245 252 347
Cash & Equivalents		 0.01 0.01 0.03 0.01 0.01 0.01 0.08 0.00 0.00 0.00 15
Accounts Receivable		 80 80 90 97 102 106 106 97 99 104 163
Inventories, net		 92 96 101 106 129 131 147 134 136 137 154
Prepaid Expenses		 8.76 9.13 10 9.16 11 11 9.26 12 11 10 15
Plant, Property, & Equipment, net		 2,178 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3,048
Total Noncurrent Assets		 315 2,472 2,479 2,483 2,555 2,566 2,541 2,470 2,426 2,408 339
Goodwill		 - - - - - - - - - - 117
Intangible Assets		 282 268 260 253 238 231 224 209 202 194 185
Other Noncurrent Operating Assets		 33 2,204 2,219 2,230 2,317 2,335 2,318 2,261 2,225 2,213 37
Total Liabilities & Shareholders' Equity		 2,673 2,489 2,691 2,706 2,804 2,822 2,804 2,713 2,671 2,659 3,734
Total Liabilities		 2,261 2,349 2,422 2,480 2,662 2,714 2,742 2,725 2,719 2,736 3,418
Total Current Liabilities		 158 156 187 178 174 205 183 166 193 185 224
Accounts Payable		 39 39 37 37 34 36 32 34 36 41 52
Accrued Expenses		 59 55 88 78 74 103 84 68 92 78 91
Current Deferred Revenue		 60 62 63 63 65 66 68 64 64 65 81
Total Noncurrent Liabilities		 2,580 2,193 2,234 2,302 2,489 2,509 2,559 2,559 2,526 2,551 3,194
Long-Term Debt		 2,078 2,170 2,213 2,276 2,463 2,484 2,532 2,536 2,504 2,529 2,980
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - - - - 195
Other Noncurrent Operating Liabilities		 502 23 22 26 26 25 27 23 23 22 19
Commitments & Contingencies		 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -65 -168 -208 -251 -290 -61 -107 -181 -121 -150 317
Total Preferred & Common Equity		 -65 -168 -208 -251 -290 -61 -107 -181 -121 -150 317
Total Common Equity		 -65 -168 -208 -251 -290 -61 -107 -181 -121 -150 317
Common Stock		 -74 - -217 -259 -290 -61 -107 -181 -121 -150 317

Annual Metrics And Ratios for USA Compression Partners

This table displays calculated financial ratios and metrics derived from USA Compression Partners' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 22.14% -2.44% 4.82% -86.46% 3,628.99% -52.20% -5.25% 11.37% 20.09% 12.32% 5.01%
EBITDA Growth		 -144.24% 363.20% -175.24% 394.94% -1.29% -177.52% 279.17% 6.11% 17.46% 17.01% 5.62%
EBIT Growth		 -460.80% 80.01% -869.83% 124.86% -36.65% -1,222.68% 130.33% 20.15% 37.03% 26.91% 4.09%
NOPAT Growth		 -353.72% 80.12% -874.50% 124.86% 248.83% -304.04% 139.90% 26.17% 38.85% 26.63% 1.97%
Net Income Growth		 -718.43% 82.53% -882.53% 96.01% 470.88% -1,619.81% 101.73% 194.95% 125.17% 45.86% 11.79%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 93.99% 52.50% 205.26% 260.00% 18.06%
Operating Cash Flow Growth		 125.78% 10.79% 4.53% 66.48% 32.80% -2.46% -9.47% -1.82% 4.33% 25.54% 15.51%
Free Cash Flow Firm Growth		 -68.26% 110.91% -4,736.52% -64.61% 113.85% 67.55% -27.71% -22.59% -29.01% 57.35% 52.10%
Invested Capital Growth		 22.58% -6.02% 142.35% 117.67% -2.90% -21.89% -6.94% -3.29% 2.09% 0.44% -5.03%
Revenue Q/Q Growth		 2.90% 1.66% -0.27% -92.27% 859.60% -51.59% -34.57% 4.47% 4.31% 2.24% 0.66%
EBITDA Q/Q Growth		 -141.83% 441.81% -166.96% 1,472.31% -29.59% 34.86% 1.35% 2.46% 4.52% 4.13% 1.84%
EBIT Q/Q Growth		 -530.76% 79.11% -301.45% 129.53% -74.32% 19.76% 3.79% 6.52% 8.62% 5.61% 2.59%
NOPAT Q/Q Growth		 -401.58% 79.24% -302.64% 129.53% -1.60% -2.79% 11.43% 6.93% 10.56% 2.23% 0.73%
Net Income Q/Q Growth		 -1,213.32% 82.03% -363.41% 96.02% -2.26% -1.84% 80.33% 21.00% 7.01% 14.48% 2.13%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.98% 24.00% 33.33% 28.57% 7.59%
Operating Cash Flow Q/Q Growth		 36.01% -7.08% 2.41% 31.69% -0.48% 2.03% -5.85% 0.40% 3.62% 12.75% 2.41%
Free Cash Flow Firm Q/Q Growth		 -33.10% -95.98% -45.72% 37.13% 10.35% 8.07% -8.11% -66.35% 161.86% 44.95% -2.72%
Invested Capital Q/Q Growth		 2.21% 63,649.40% 121.13% -0.47% -1.25% -3.05% -1.72% 22.58% 0.64% -2.45% -2.03%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 54.75% -473.27% 83.73% 69.16% 69.27% 66.74% 66.35% 100.00% 67.06%
EBITDA Margin		 -17.98% 48.51% -34.82% 758.55% 20.08% -32.56% 61.57% 58.66% 57.37% 59.77% 60.11%
Operating Margin		 -50.12% -10.21% -94.94% 174.37% 12.06% -69.62% 22.27% 24.03% 27.42% 30.98% 30.71%
EBIT Margin		 -50.11% -10.27% -95.02% 174.48% 2.96% -69.61% 22.28% 24.04% 27.43% 30.99% 30.72%
Profit (Net Income) Margin		 -57.02% -10.21% -95.69% -28.17% 2.80% -89.07% 1.62% 4.30% 8.07% 10.48% 11.15%
Tax Burden Percent		 100.71% 99.40% 100.70% 81.01% 94.71% 100.22% 92.16% 96.76% 98.04% 97.81% 95.81%
Interest Burden Percent		 112.98% 100.00% 100.00% -19.93% 99.81% 127.68% 7.91% 18.50% 30.00% 34.56% 37.90%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 5.29% 0.00% 7.84% 3.24% 1.96% 2.19% 4.19%
Return on Invested Capital (ROIC)		 -14.34% -2.67% -15.67% 1.73% 4.48% -10.41% 4.91% 6.53% 9.12% 11.41% 11.91%
ROIC Less NNEP Spread (ROIC-NNEP)		 -23.30% -3.81% -39.41% -11.45% -4.41% -24.66% -1.39% -0.18% 1.96% 3.62% 4.64%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% -16.13% -2.21% -2.70% -37.69% -3.53% -0.70% 15.97% 83.06% -274.62%
Return on Equity (ROE)		 0.00% 0.00% -31.80% -0.48% 1.77% -48.10% 1.38% 5.83% 25.10% 94.47% -262.72%
Cash Return on Invested Capital (CROIC)		 -34.63% 3.54% -98.84% -72.35% 7.42% 14.17% 12.10% 9.88% 7.06% 10.96% 17.07%
Operating Return on Assets (OROA)		 -8.96% -1.82% -16.48% 2.38% 1.10% -13.92% 4.93% 6.23% 8.59% 10.75% 11.43%
Return on Assets (ROA)		 -10.20% -1.81% -16.59% -0.38% 1.04% -17.81% 0.36% 1.12% 2.53% 3.63% 4.15%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% 0.47% -29.53% 0.40% -0.09% -18.89% -194.64% -786.05%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 3.31% -176.14% 10.17% -26.07% -23.28% -70.60% 0.00%
Net Operating Profit after Tax (NOPAT)		 -95 -19 -184 46 159 -325 130 164 227 288 294
NOPAT Margin		 -35.09% -7.15% -66.46% 122.06% 11.42% -48.74% 20.52% 23.25% 26.88% 30.30% 29.42%
Net Nonoperating Expense Percent (NNEP)		 8.96% 1.14% 23.74% 13.19% 8.88% 14.25% 6.29% 6.71% 7.17% 7.79% 7.27%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 8.23% 11.13% 12.20% 12.18%
Cost of Revenue to Revenue		 0.00% 0.00% 45.25% 573.27% 16.27% 30.84% 30.73% 33.26% 33.65% 0.00% 32.94%
SG&A Expenses to Revenue		 15.14% 8.62% 9.02% 184.20% 4.61% 8.98% 8.86% 8.70% 8.59% 7.65% 6.65%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 150.12% 110.21% 149.69% -647.64% 59.61% 138.78% 47.01% 42.72% 38.94% 69.02% 36.35%
Earnings before Interest and Taxes (EBIT)		 -136 -27 -263 65 41 -465 141 169 232 295 307
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -49 128 -96 284 280 -217 390 413 485 568 600
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 2.71 13.23 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 236.72 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.50 -0.22 1.69 0.00 0.00 1.37 2.11 2.21 2.44 2.78 2.74
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.66 32.23 26.51
Dividend Yield		 52.06% 30.25% 28.00% 31.56% 19.99% 22.23% 15.24% 13.20% 10.25% 9.10% 9.33%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.99% 3.10% 3.77%
Enterprise Value to Invested Capital (EV/IC)		 1.19 0.00 1.28 0.00 0.00 1.21 1.52 1.68 1.94 2.10 2.18
Enterprise Value to Revenue (EV/Rev)		 3.20 0.00 7.69 0.00 0.00 4.97 6.15 5.88 5.76 5.59 5.26
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 9.99 10.02 10.04 9.36 8.74
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 27.59 24.44 21.00 18.04 17.11
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 29.96 25.27 21.44 18.45 17.87
Enterprise Value to Operating Cash Flow (EV/OCF)		 7.37 0.00 15.65 0.00 0.00 11.32 14.65 15.89 17.93 15.57 13.31
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 7.49 12.15 16.70 27.71 19.20 12.46
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.64 1.12 2.36 2.90 5.84 12.76 90.16 -22.43
Long-Term Debt to Equity		 0.00 0.00 0.00 0.64 1.12 2.36 2.90 5.84 12.76 90.16 -22.43
Financial Leverage		 0.00 0.00 0.41 0.19 0.61 1.53 2.54 3.82 8.17 22.95 -59.21
Leverage Ratio		 0.00 0.00 1.92 1.24 1.70 2.70 3.83 5.22 9.93 26.01 -63.31
Compound Leverage Factor		 0.00 0.00 1.92 -0.25 1.70 3.45 0.30 0.97 2.98 8.99 -23.99
Debt to Total Capital		 100.00% 100.00% 0.00% 38.95% 52.77% 70.28% 74.38% 85.37% 92.73% 98.90% 104.67%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 100.00% 100.00% 0.00% 38.95% 52.77% 70.28% 74.38% 85.37% 92.73% 98.90% 104.67%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 100.00% 61.06% 13.60% 17.41% 21.80% 19.34% 18.91% 6.67% 0.00%
Common Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 33.63% 12.31% 3.81% -4.71% -11.64% -5.57% -4.67%
Debt to EBITDA		 -14.99 5.35 0.00 6.19 6.60 -8.86 5.07 5.10 4.81 4.41 4.21
Net Debt to EBITDA		 -14.99 5.35 0.00 6.19 6.60 -8.86 5.07 5.10 4.81 4.41 4.19
Long-Term Debt to EBITDA		 -14.99 5.35 0.00 6.19 6.60 -8.86 5.07 5.10 4.81 4.41 4.21
Debt to NOPAT		 -7.68 -36.32 0.00 38.48 11.62 -5.92 15.20 12.86 10.27 8.69 8.59
Net Debt to NOPAT		 -7.68 -36.32 0.00 38.47 11.62 -5.92 15.20 12.86 10.27 8.69 8.57
Long-Term Debt to NOPAT		 -7.68 -36.32 0.00 38.48 11.62 -5.92 15.20 12.86 10.27 8.69 8.59
Altman Z-Score		 -0.07 0.00 4.85 0.00 0.00 -0.02 0.77 0.88 1.09 1.30 1.39
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 100.00% 100.00% 73.26% 38.60% 70.64% 101.46% 175.28% 306.03% -199.20%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.86 1.29 1.58 1.46 1.22 1.17 1.09 1.07 1.21 1.23 1.27
Quick Ratio		 0.51 0.73 0.78 0.85 0.72 0.66 0.60 0.48 0.51 0.47 0.49
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -229 25 -1,159 -1,909 264 443 320 248 176 277 421
Operating Cash Flow to CapEx		 42.03% 353.75% 95.44% 87.36% 202.18% 275.50% 651.40% 199.62% 116.59% 167.72% 342.76%
Free Cash Flow to Firm to Interest Expense		 -13.02 0.00 0.00 -24.35 2.08 3.44 2.47 1.80 1.04 1.40 2.21
Operating Cash Flow to Interest Expense		 6.67 0.00 0.00 2.89 2.36 2.28 2.04 1.89 1.60 1.72 2.07
Operating Cash Flow Less CapEx to Interest Expense		 -9.20 0.00 0.00 -0.42 1.19 1.45 1.73 0.94 0.23 0.69 1.47
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.18 0.18 0.17 0.01 0.37 0.20 0.22 0.26 0.31 0.35 0.37
Accounts Receivable Turnover		 9.08 7.26 7.48 0.47 10.59 5.36 5.61 7.15 9.44 10.30 11.63
Inventory Turnover		 0.00 0.00 3.99 3.51 2.51 2.33 2.28 2.61 2.73 0.00 2.45
Fixed Asset Turnover		 0.22 0.20 0.22 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 15.17 15.58 9.90 11.69 10.78 8.10 7.58 0.00 11.86
Days Sales Outstanding (DSO)		 40.19 50.31 48.82 778.52 34.47 68.13 65.09 51.03 38.67 35.43 31.37
Days Inventory Outstanding (DIO)		 0.00 0.00 91.51 103.89 145.27 156.46 160.02 139.85 133.64 0.00 148.97
Days Payable Outstanding (DPO)		 0.00 0.00 24.06 23.42 36.85 31.22 33.86 45.05 48.13 0.00 30.79
Cash Conversion Cycle (CCC)		 40.19 50.31 116.26 858.99 142.89 193.37 191.25 145.84 124.18 35.43 149.55
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 729 685 1,661 3,615 3,510 2,742 2,552 2,468 2,519 2,530 2,403
Invested Capital Turnover		 0.41 0.37 0.24 0.01 0.39 0.21 0.24 0.28 0.34 0.38 0.40
Increase / (Decrease) in Invested Capital		 134 -44 976 1,954 -105 -768 -190 -84 52 11 -127
Enterprise Value (EV)		 865 0.00 2,127 0.00 0.00 3,319 3,890 4,140 4,875 5,315 5,246
Market Capitalization		 136 -58 467 0.00 0.00 915 1,338 1,556 2,063 2,644 2,731
Book Value per Share		 $0.00 $0.00 $0.00 $0.00 $12.22 $3.48 $1.04 ($1.19) ($2.98) ($1.21) ($0.92)
Tangible Book Value per Share		 ($2.22) ($2.01) ($7.28) ($10.50) $2.05 $0.04 ($2.09) ($3.99) ($5.48) ($3.05) ($2.44)
Total Capital		 729 685 1,665 4,517 3,510 2,742 2,653 2,468 2,519 2,530 2,411
Total Debt		 729 685 0.00 1,759 1,852 1,927 1,973 2,107 2,336 2,503 2,524
Total Long-Term Debt		 729 685 0.00 1,759 1,852 1,927 1,973 2,107 2,336 2,503 2,524
Net Debt		 729 685 -4.01 1,759 1,852 1,927 1,973 2,107 2,336 2,503 2,515
Capital Expenditures (CapEx)		 279 37 142 259 149 106 41 131 233 204 115
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -8.46 16 23 68 42 29 17 13 39 44 41
Debt-free Net Working Capital (DFNWC)		 -8.46 17 27 68 42 29 17 13 39 44 50
Net Working Capital (NWC)		 -8.46 17 27 68 42 29 17 13 39 44 50
Net Nonoperating Expense (NNE)		 59 8.08 81 56 120 269 120 133 159 188 182
Net Nonoperating Obligations (NNO)		 729 685 -4.01 857 1,852 1,927 1,872 2,107 2,336 2,503 2,515
Total Depreciation and Amortization (D&A)		 87 155 167 219 239 247 249 244 253 274 293
Debt-free, Cash-free Net Working Capital to Revenue		 -3.13% 6.25% 8.34% 181.66% 2.97% 4.39% 2.74% 1.81% 4.60% 4.66% 4.12%
Debt-free Net Working Capital to Revenue		 -3.13% 6.27% 9.79% 181.92% 2.97% 4.39% 2.74% 1.81% 4.60% 4.66% 4.98%
Net Working Capital to Revenue		 -3.13% 6.27% 9.79% 181.92% 2.97% 4.39% 2.74% 1.81% 4.60% 4.66% 4.98%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($3.15) $0.00 $0.00 $0.00 ($2.15) ($6.65) $0.00 ($0.19) $0.21 $0.72 $0.85
Adjusted Weighted Average Basic Shares Outstanding		 34.11M 53.04K 61.56M 96.40M 96.65M 97.00M 97.38M 97.78M 98.63M 113.39M 120.76M
Adjusted Diluted Earnings per Share		 ($3.15) $0.00 $0.00 $0.00 ($2.15) ($6.65) $0.00 ($0.19) $0.20 $0.72 $0.85
Adjusted Weighted Average Diluted Shares Outstanding		 34.11M 53.34K 61.84M 96.40M 96.65M 97.00M 97.38M 97.78M 100.68M 114.50M 121.27M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($2.15) ($6.65) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 52.60M 60.69M 62.19M 96.40M 96.59M 96.82M 97.38M 97.78M 98.63M 113.39M 120.76M
Normalized Net Operating Profit after Tax (NOPAT)		 44 -19 -28 61 166 114 132 167 238 294 305
Normalized NOPAT Margin		 16.25% -7.12% -10.13% 162.48% 11.88% 17.07% 20.89% 23.66% 28.12% 30.90% 30.54%
Pre Tax Income Margin		 -56.62% -10.27% -95.02% -34.77% 2.96% -88.87% 1.76% 4.45% 8.23% 10.71% 11.64%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -7.70 0.00 0.00 0.83 0.33 -3.61 1.09 1.23 1.37 1.48 1.61
NOPAT to Interest Expense		 -5.39 0.00 0.00 0.58 1.25 -2.53 1.00 1.19 1.34 1.45 1.54
EBIT Less CapEx to Interest Expense		 -23.57 0.00 0.00 -2.47 -0.84 -4.44 0.77 0.28 -0.01 0.46 1.01
NOPAT Less CapEx to Interest Expense		 -21.26 0.00 0.00 -2.72 0.09 -3.36 0.69 0.24 -0.03 0.43 0.94
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -29.22% -335.39% 0.00% -1,578.68% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -29.22% -335.39% 0.00% -1,578.68% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for USA Compression Partners

This table displays calculated financial ratios and metrics derived from USA Compression Partners' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 144,972,358.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 144,972,358.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.26
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 20.86% 18.38% 16.31% 13.72% 10.54% 9.26% 6.96% 6.29% 4.29% 2.68% 35.09%
EBITDA Growth		 23.29% 19.38% 17.58% 27.90% 6.63% 17.43% 0.80% 1.08% 13.20% 7.74% 27.00%
EBIT Growth		 42.73% 39.41% 30.98% 50.33% 7.87% 24.02% -8.27% -4.85% 20.84% 11.22% 31.71%
NOPAT Growth		 38.74% 48.98% 32.51% 50.80% 20.71% 9.57% -1.52% -0.88% 7.93% 2.78% 27.85%
Net Income Growth		 117.46% 53.49% 115.46% 32.45% -7.54% 98.09% -12.99% -8.58% 78.44% 9.13% 86.92%
EPS Growth		 400.00% 125.00% 2,000.00% 109.09% 44.44% 1,600.00% -26.32% -4.35% 100.00% 35.29% -100.00%
Operating Cash Flow Growth		 1.75% 11.58% 55.69% 10.09% -3.18% 42.13% -17.09% 28.43% 56.51% 7.14% 57.55%
Free Cash Flow Firm Growth		 -168.60% -88.20% -153.01% 92.12% 95.80% 307.37% 343.02% 730.78% 1,317.56% 227.12% -567.06%
Invested Capital Growth		 24.35% 2.09% 5.05% 4.42% 3.63% 0.44% -3.08% -5.25% -5.45% -5.03% 30.04%
Revenue Q/Q Growth		 4.91% 3.67% 1.88% 2.63% 1.98% 2.47% -0.27% 1.99% 0.05% 0.89% 31.21%
EBITDA Q/Q Growth		 14.99% -0.70% -0.53% 9.70% -4.14% 9.36% -6.53% 5.38% 5.09% -4.07% 19.55%
EBIT Q/Q Growth		 25.11% 1.11% -2.42% 15.68% -10.23% 16.25% -14.06% 10.38% 9.58% -8.77% 19.36%
NOPAT Q/Q Growth		 19.11% 10.76% -1.71% 16.29% -4.65% 0.54% -11.66% 17.06% 3.82% -4.26% 9.88%
Net Income Q/Q Growth		 -11.37% -38.57% 83.58% 32.52% -38.13% 31.61% -19.36% 39.23% 20.76% -19.51% 38.12%
EPS Q/Q Growth		 -18.18% -88.89% 1,800.00% 21.05% -43.48% 30.77% -17.65% 57.14% 18.18% -11.54% -100.00%
Operating Cash Flow Q/Q Growth		 -43.02% 82.94% -28.04% 46.76% -49.89% 168.55% -58.02% 127.34% -38.93% 83.83% -38.27%
Free Cash Flow Firm Q/Q Growth		 -0.91% 103.53% -491.72% 43.62% 46.22% 442.99% 133.68% 46.34% 3.81% -7.85% -433.65%
Invested Capital Q/Q Growth		 0.86% 0.64% 3.38% -0.49% 0.08% -2.45% -0.24% -2.72% -0.12% -2.03% 36.60%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 65.48% 67.48% 67.26% 66.78% 65.91% 195.59% 66.72% 65.42% 69.25% 66.84% 64.41%
EBITDA Margin		 60.04% 57.51% 57.64% 61.61% 57.91% 61.81% 57.92% 59.85% 62.86% 59.77% 54.46%
Operating Margin		 28.08% 30.46% 29.17% 32.88% 31.54% 30.31% 28.30% 30.63% 33.54% 30.33% 27.59%
EBIT Margin		 29.67% 28.94% 29.18% 32.89% 28.95% 32.85% 28.31% 30.63% 33.55% 30.34% 27.60%
Profit (Net Income) Margin		 9.63% 5.71% 10.28% 13.28% 8.05% 10.34% 8.36% 11.42% 13.78% 10.99% 11.57%
Tax Burden Percent		 98.79% 97.31% 98.04% 98.54% 96.06% 98.06% 93.04% 98.65% 93.48% 98.11% 90.29%
Interest Burden Percent		 32.85% 20.26% 35.94% 40.96% 28.96% 32.11% 31.76% 37.78% 43.94% 36.94% 46.44%
Effective Tax Rate		 1.21% 2.69% 1.96% 1.46% 3.94% 1.94% 6.96% 1.35% 6.52% 1.89% 9.71%
Return on Invested Capital (ROIC)		 9.97% 10.06% 9.88% 11.58% 11.05% 11.19% 9.92% 11.75% 12.32% 12.04% 9.30%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.16% 7.63% 8.13% 9.66% 8.83% 9.22% 8.16% 9.86% 10.58% 10.15% 7.70%
Return on Net Nonoperating Assets (RNNOA)		 219.86% 62.33% 138.35% 120.48% 147.32% 211.62% 313.90% 824.97% -3,510.87% -601.09% 138.96%
Return on Equity (ROE)		 229.82% 72.39% 148.23% 132.06% 158.37% 222.81% 323.82% 836.71% -3,498.55% -589.05% 148.26%
Cash Return on Invested Capital (CROIC)		 -12.60% 7.06% 4.65% 6.28% 7.49% 10.96% 14.32% 16.74% 17.15% 17.07% -15.42%
Operating Return on Assets (OROA)		 8.95% 9.07% 9.39% 10.82% 9.77% 11.39% 9.92% 10.94% 12.18% 11.29% 9.28%
Return on Assets (ROA)		 2.90% 1.79% 3.31% 4.37% 2.72% 3.59% 2.93% 4.08% 5.00% 4.09% 3.89%
Return on Common Equity (ROCE)		 -448.90% -54.50% -240.57% -94.41% -196.62% -459.06% -1,172.09% -2,562.09% -59,039.52% -1,762.44% 66.14%
Return on Equity Simple (ROE_SIMPLE)		 -25.45% 0.00% -27.94% -144.77% -81.10% 0.00% -53.41% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 60 67 66 76 73 73 65 76 78 75 83
NOPAT Margin		 27.74% 29.64% 28.59% 32.40% 30.29% 29.72% 26.33% 30.21% 31.35% 29.75% 24.92%
Net Nonoperating Expense Percent (NNEP)		 1.81% 2.42% 1.75% 1.92% 2.22% 1.97% 1.76% 1.89% 1.74% 1.89% 1.61%
Return On Investment Capital (ROIC_SIMPLE)		 - 3.27% - - - 3.09% 2.74% 3.17% 3.30% 3.12% 2.50%
Cost of Revenue to Revenue		 34.52% 32.52% 32.74% 33.22% 34.09% -95.59% 33.28% 34.58% 30.75% 33.16% 35.59%
SG&A Expenses to Revenue		 9.25% 8.26% 9.96% 6.02% 6.40% 8.26% 7.69% 5.16% 6.67% 7.09% 10.67%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 37.41% 37.02% 38.09% 33.90% 34.37% 165.28% 38.42% 34.79% 35.71% 36.51% 36.82%
Earnings before Interest and Taxes (EBIT)		 64 65 67 77 69 81 69 77 84 77 91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 130 129 132 145 139 152 142 150 157 151 180
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.02
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 259.48
Price to Revenue (P/Rev)		 2.65 2.44 3.08 3.02 2.85 2.78 3.23 2.90 2.91 2.74 3.51
Price to Earnings (P/E)		 142.73 100.66 66.11 48.58 42.28 32.23 39.56 36.11 29.97 26.51 30.40
Dividend Yield		 9.81% 10.25% 8.04% 9.05% 9.38% 9.10% 7.95% 8.83% 8.95% 9.33% 7.89%
Earnings Yield		 0.70% 0.99% 1.51% 2.06% 2.37% 3.10% 2.53% 2.77% 3.34% 3.77% 3.29%
Enterprise Value to Invested Capital (EV/IC)		 1.96 1.94 2.15 2.08 2.06 2.10 2.31 2.21 2.24 2.18 2.06
Enterprise Value to Revenue (EV/Rev)		 6.04 5.76 6.38 5.95 5.75 5.59 6.03 5.52 5.54 5.26 6.25
Enterprise Value to EBITDA (EV/EBITDA)		 10.55 10.04 11.08 10.04 9.80 9.36 10.24 9.50 9.32 8.74 10.61
Enterprise Value to EBIT (EV/EBIT)		 22.93 21.00 22.58 19.69 19.17 18.04 20.22 19.06 18.37 17.11 20.61
Enterprise Value to NOPAT (EV/NOPAT)		 23.82 21.44 23.01 20.04 18.98 18.45 20.30 18.93 18.83 17.87 21.81
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.68 17.93 18.95 17.72 17.66 15.57 17.66 15.16 14.26 13.31 15.91
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 27.71 47.36 33.86 28.00 19.20 15.87 12.83 12.68 12.46 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 10.04 12.76 17.36 23.08 41.14 90.16 -213.09 -52.14 -32.93 -22.43 9.41
Long-Term Debt to Equity		 10.04 12.76 17.36 23.08 41.14 90.16 -213.09 -52.14 -32.93 -22.43 9.41
Financial Leverage		 26.94 8.17 17.01 12.47 16.68 22.95 38.47 83.65 -331.76 -59.21 18.05
Leverage Ratio		 33.29 9.93 19.35 14.63 19.12 26.01 42.46 92.12 -358.05 -63.31 21.16
Compound Leverage Factor		 10.93 2.01 6.96 5.99 5.54 8.35 13.49 34.81 -157.34 -23.39 9.83
Debt to Total Capital		 90.94% 92.73% 94.55% 95.85% 97.63% 98.90% 100.47% 101.96% 103.13% 104.67% 90.40%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 90.94% 92.73% 94.55% 95.85% 97.63% 98.90% 100.47% 101.96% 103.13% 104.67% 90.40%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 19.07% 18.91% 16.56% 6.51% 6.51% 6.67% 6.69% 2.99% 2.99% 0.00% 0.00%
Common Equity to Total Capital		 -10.01% -11.64% -11.12% -2.36% -4.13% -5.57% -7.16% -4.94% -6.12% -4.67% 9.60%
Debt to EBITDA		 4.90 4.81 4.87 4.63 4.64 4.41 4.46 4.39 4.29 4.21 4.67
Net Debt to EBITDA		 4.90 4.81 4.87 4.63 4.64 4.41 4.46 4.39 4.29 4.19 4.65
Long-Term Debt to EBITDA		 4.90 4.81 4.87 4.63 4.64 4.41 4.46 4.39 4.29 4.21 4.67
Debt to NOPAT		 11.07 10.27 10.12 9.23 8.99 8.69 8.83 8.74 8.68 8.59 9.60
Net Debt to NOPAT		 11.07 10.27 10.12 9.23 8.99 8.69 8.83 8.74 8.68 8.57 9.55
Long-Term Debt to NOPAT		 11.07 10.27 10.12 9.23 8.99 8.69 8.83 8.74 8.68 8.59 9.60
Altman Z-Score		 0.92 0.89 1.03 1.04 1.03 1.05 1.16 1.11 1.14 1.10 1.08
Noncontrolling Interest Sharing Ratio		 295.32% 175.28% 262.30% 171.49% 224.16% 306.03% 461.96% 406.21% -1,587.54% -199.20% 55.39%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.26 1.21 1.43 1.25 1.43 1.23 1.47 1.27 1.36 1.27 1.55
Quick Ratio		 0.55 0.51 0.59 0.52 0.58 0.47 0.59 0.51 0.56 0.49 0.79
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -430 15 -60 -34 -18 62 145 212 220 203 -676
Operating Cash Flow to CapEx		 102.99% 115.57% 66.87% 200.95% 170.83% 458.09% 301.79% 555.80% 324.53% 272.54% 364.44%
Free Cash Flow to Firm to Interest Expense		 -9.94 0.34 -1.15 -0.69 -0.37 1.27 3.05 4.44 4.67 4.19 -13.80
Operating Cash Flow to Interest Expense		 1.16 2.04 1.28 1.98 0.98 2.68 1.15 2.61 1.61 2.89 1.76
Operating Cash Flow Less CapEx to Interest Expense		 0.03 0.28 -0.63 1.00 0.41 2.09 0.77 2.14 1.12 1.83 1.28
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.30 0.31 0.32 0.33 0.34 0.35 0.35 0.36 0.36 0.37 0.34
Accounts Receivable Turnover		 9.17 9.44 9.65 9.26 9.13 10.30 9.71 9.59 9.44 11.63 8.33
Inventory Turnover		 2.80 2.73 2.60 2.59 2.43 0.00 0.05 0.11 0.07 2.45 2.53
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 7.27 7.58 7.95 8.34 8.98 0.00 0.19 0.42 0.27 11.86 8.45
Days Sales Outstanding (DSO)		 39.80 38.67 37.84 39.42 39.97 35.43 37.59 38.08 38.68 31.37 43.81
Days Inventory Outstanding (DIO)		 130.37 133.64 140.51 140.92 149.92 0.00 7,350.60 3,272.22 5,175.77 148.97 144.31
Days Payable Outstanding (DPO)		 50.18 48.13 45.91 43.77 40.65 0.00 1,911.23 878.74 1,331.85 30.79 43.18
Cash Conversion Cycle (CCC)		 119.99 124.18 132.44 136.57 149.24 35.43 5,476.96 2,431.56 3,882.60 149.55 144.95
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,503 2,519 2,604 2,592 2,594 2,530 2,524 2,456 2,453 2,403 3,282
Invested Capital Turnover		 0.36 0.34 0.35 0.36 0.36 0.38 0.38 0.39 0.39 0.40 0.37
Increase / (Decrease) in Invested Capital		 490 52 125 110 91 11 -80 -136 -141 -127 758
Enterprise Value (EV)		 4,901 4,875 5,599 5,392 5,348 5,315 5,829 5,420 5,490 5,246 6,773
Market Capitalization		 2,147 2,063 2,705 2,739 2,647 2,644 3,124 2,843 2,887 2,731 3,808
Book Value per Share		 ($2.55) ($2.98) ($2.82) ($0.52) ($0.92) ($1.21) ($1.54) ($1.03) ($1.22) ($0.92) $2.18
Tangible Book Value per Share		 ($5.12) ($5.48) ($5.15) ($2.50) ($2.83) ($3.05) ($3.32) ($2.75) ($2.81) ($2.44) $0.10
Total Capital		 2,503 2,519 2,604 2,592 2,594 2,530 2,524 2,456 2,453 2,411 3,297
Total Debt		 2,276 2,336 2,463 2,484 2,532 2,503 2,536 2,504 2,529 2,524 2,980
Total Long-Term Debt		 2,276 2,336 2,463 2,484 2,532 2,503 2,536 2,504 2,529 2,524 2,980
Net Debt		 2,276 2,336 2,463 2,484 2,532 2,503 2,536 2,504 2,529 2,515 2,966
Capital Expenditures (CapEx)		 49 79 99 48 28 28 18 22 23 51 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 46 39 75 51 79 44 77 52 67 41 108
Debt-free Net Working Capital (DFNWC)		 46 39 75 51 79 44 77 52 67 50 123
Net Working Capital (NWC)		 46 39 75 51 79 44 77 52 67 50 123
Net Nonoperating Expense (NNE)		 39 54 42 45 53 48 44 47 44 47 44
Net Nonoperating Obligations (NNO)		 2,276 2,336 2,463 2,484 2,532 2,503 2,536 2,504 2,529 2,515 2,966
Total Depreciation and Amortization (D&A)		 66 64 65 68 69 71 73 73 73 74 89
Debt-free, Cash-free Net Working Capital to Revenue		 5.67% 4.60% 8.55% 5.65% 8.51% 4.66% 7.99% 5.31% 6.74% 4.12% 9.97%
Debt-free Net Working Capital to Revenue		 5.67% 4.60% 8.55% 5.65% 8.52% 4.66% 7.99% 5.31% 6.74% 4.98% 11.31%
Net Working Capital to Revenue		 5.67% 4.60% 8.55% 5.65% 8.52% 4.66% 7.99% 5.31% 6.74% 4.98% 11.31%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.09 $0.01 $0.19 $0.23 $0.13 $0.17 $0.14 $0.22 $0.27 $0.22 $0.27
Adjusted Weighted Average Basic Shares Outstanding		 98.29M 98.63M 102.54M 116.85M 117.02M 113.39M 117.51M 119.00M 122.68M 120.76M 142.75M
Adjusted Diluted Earnings per Share		 $0.09 $0.01 $0.19 $0.23 $0.13 $0.17 $0.14 $0.22 $0.26 $0.23 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 100.26M 100.68M 103.61M 117.97M 118.26M 114.50M 118.25M 119.50M 123.09M 121.27M 143.13M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 98.29M 98.63M 102.54M 116.85M 117.02M 113.39M 117.51M 119.00M 122.68M 120.76M 142.75M
Normalized Net Operating Profit after Tax (NOPAT)		 57 69 67 77 73 77 69 79 80 77 82
Normalized NOPAT Margin		 26.38% 30.62% 29.13% 32.52% 30.24% 31.49% 28.21% 31.51% 31.89% 30.50% 24.77%
Pre Tax Income Margin		 9.75% 5.86% 10.49% 13.47% 8.38% 10.55% 8.99% 11.57% 14.74% 11.21% 12.82%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.49 1.45 1.30 1.59 1.41 1.66 1.47 1.61 1.78 1.59 1.87
NOPAT to Interest Expense		 1.39 1.49 1.27 1.56 1.47 1.50 1.36 1.59 1.67 1.56 1.69
EBIT Less CapEx to Interest Expense		 0.37 -0.32 -0.61 0.60 0.83 1.08 1.08 1.14 1.29 0.53 1.38
NOPAT Less CapEx to Interest Expense		 0.27 -0.28 -0.64 0.58 0.90 0.92 0.98 1.12 1.17 0.50 1.20
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, investor-focused trend snapshot for USA Compression Partners (NYSE: USAC) based on the quarterly statements from 2022 through 2025. The bullets below highlight the most material positives, neutrals, and negatives observed over the four-year window. Positive items come first, then neutral, and finally negative.

  • Revenue trend: Operating revenue rose from about $190.1 million in 2022 Q4 to about $252.5 million in 2025 Q4, roughly +32% over the period, signaling sustained top-line growth.
  • Profitability progress: Net income attributable to common shareholders increased from around $8.37 million in 2022 Q4 to about $32.5 million at the 2025 Q3 peak (roughly $27.8 million in 2025 Q4), indicating improving profitability over time.
  • Operating cash flow resilience: Net cash from continuing operating activities remained robust and generally trended higher, with examples like about $129.3 million in 2024 Q4 and about $139.5 million in 2025 Q4 (plus ~$124.2 million in 2025 Q2). This supports capex and debt service needs.
  • Shareholder returns: Cash dividends per share were consistently $0.53 across multiple quarters, providing a steady income stream for investors.
  • Scale of assets: The company maintains a sizable asset base, with total assets hovering around $2.7 billion over the period, reflecting a scalable platform in its niche.
  • Liquidity caveat: Cash and cash equivalents are often reported near zero in several quarters (including 2025 Q3), signaling tight near-term liquidity despite positive operating cash flow in many periods.
  • Balance-sheet quirks: Some quarters show negative equity values due to restatements or unusual accounting entries, which can create confusion about the current equity position even if solvency remains manageable.
  • Debt activity mix: Periodic debt issuance (e.g., about $1.02 billion in 2025 Q4) paired with sizable repayments yields a net neutral near-term cash impact but expands future interest obligations.
  • Leverage and interest burden: Long-term debt sits around $2.5 billion, with quarterly interest expense in the mid-$40s to mid-$50s millions range, placing a substantial ongoing burden on cash flow.
  • Financing cash outflows: Net cash from financing activities has been negative across many quarters (for example, -$101.89 million in 2025 Q2 and -$79.74 million in 2025 Q4), indicating continued reliance on external financing for liquidity and growth.
05/15/26 11:03 AM ETAI Generated. May Contain Errors.

USA Compression Partners Financials - Frequently Asked Questions

According to the most recent income statement we have on file, USA Compression Partners' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

USA Compression Partners' net income appears to be on a downward trend, with a most recent value of $111.32 million in 2025, falling from -$154.27 million in 2015. The previous period was $99.58 million in 2024. View USA Compression Partners' forecast to see where analysts expect USA Compression Partners to go next.

USA Compression Partners' total operating income in 2025 was $306.51 million, based on the following breakdown:
  • Total Gross Profit: $669.30 million
  • Total Operating Expenses: $362.79 million

Over the last 10 years, USA Compression Partners' total revenue changed from $270.55 million in 2015 to $998.10 million in 2025, a change of 268.9%.

USA Compression Partners' total liabilities were at $2.73 billion at the end of 2025, a 0.5% increase from 2024, and a 81.0% increase since 2015.

In the past 10 years, USA Compression Partners' cash and equivalents has ranged from $0.00 in 2021 to $8.56 million in 2025, and is currently $8.56 million as of their latest financial filing in 2025.

Over the last 10 years, USA Compression Partners' book value per share changed from 0.00 in 2015 to -0.92 in 2025, a change of -91.7%.


Related Companies

Financial statements for NYSE:USAC last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel